- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04721678
Internet-administered Interpersonal Psychotherapy for Depressive Symptoms
December 8, 2023 updated by: Gerhard Andersson, Linkoeping University
INDIGO - Internet-administered Interpersonal Psychotherapy for Depressive Symptoms
The aim of the study is to test the efficacy of a treatment for depression based on interpersonal psychotherapy (IPT).
The treatment will be accessed via an internet platform built for this study.
A therapist will provide support weekly, as well as on-demand when needed.
The treatment lasts for 10 weeks.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
113
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Östergötland
-
Linköping, Östergötland, Sweden, 58183
- Department of Behavioral Sciences and Learning, Linköping University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- A diagnosis of Major depressive disorder (as indicated by the MINI 7.0 Neuropsychiatric interview) and/or depressive symptoms equal to or more severe than mild depression on the MADRS-S (equal to or above 13 points) and/or BDI (equal to or above 14 points).
- Age of at least 18 years old.
- Adequate ability to speak, write, and read Swedish.
- Internet access for the duration of the study.
Exclusion Criteria:
- Ongoing substance abuse.
- Suicidal plans.
- A diagnosed personality syndrome (as diagnosed before the study by a licensed psychiatric healthcare professional).
- Other ongoing psychological treatment.
- Other severe psychiatric comorbidity that requires specialized care (e.g. anorexia nervosa, psychosis).
- Recent changes in psychotropic medication or planned changes during the initial treatment period.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Interpersonal psychotherapy (IPT)
10 weeks of internet-administered interpersonal psychotherapy with therapist support.
|
Internet-based interpersonal psychotherapy aimed at reducing symptoms of depression.
The content of the intervention is divided into three parts: the assessment phase (the first four weeks), the focus phase (the following five weeks), and the end phase (the last week).
|
No Intervention: Wait-list control group
The participants in the control group will receive access to the treatment after the post-treatment assessment has been conducted.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change on Montgomery Åsberg Depression Rating Scale (MADRS-S)
Time Frame: Before the treatment, during week 1 to 10 of the treatment, after 11 weeks. Follow-up one year after the start of the treatment.
|
Depression inventory, consists of 9 items measuring symptoms of major depressive disorder.
Each item are scored between 0 and 6 points, resulting in a total sum between 0 and 54.
Cut-offs are: 0-12 No substantial depressive symptoms, 13-19 mild depressive symptoms, 20-34 moderate depressive symptoms, 35-54 severe depressive symptoms.
|
Before the treatment, during week 1 to 10 of the treatment, after 11 weeks. Follow-up one year after the start of the treatment.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change on Beck Depression Inventory-II (BDI-II)
Time Frame: Before treatment and after 11 weeks, follow-up one year after the start of the treatment.
|
Depression inventory consisting of 21 items measuring symptoms of depressions along with behavioural and cognitive manifestations of these symptoms.
Sum scores range between 0 and 63 points.
Cut-offs: 0-13 minimal depressive symptoms, 14-19 mild depressive symptoms, 20-28 moderate depressive symptoms, 30-63 severe depressive symptoms.
|
Before treatment and after 11 weeks, follow-up one year after the start of the treatment.
|
Change on Brunnsviken Brief Quality of Life Inventory (BBQ)
Time Frame: Before treatment and after 11 weeks, follow-up one year after the start of the treatment.
|
Measure of subjective quality of life.
Sum scores can range between 0 and 96.
Higher scores indicate a higher quality of life.
|
Before treatment and after 11 weeks, follow-up one year after the start of the treatment.
|
Change on Generalized Anxiety Disorder 7-Item Scale (GAD-7)
Time Frame: Before treatment and after 11 weeks, follow-up one year after the start of the treatment.
|
Seven item measure of generalized anxiety disorder.
Sum score range from 0 to 21, with higher scores indicating more generalized anxiety.
Cut-offs for interpretation: 0-5 minimal anxiety, 6-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe anxiety.
|
Before treatment and after 11 weeks, follow-up one year after the start of the treatment.
|
Change on Reflective Functioning Questionnaire-8 item version (RFQ-8)
Time Frame: Before treatment, after 11 weeks, following one year after the start of the treatment.
|
Instrument measuring reflective functioning related to mentalization ability.
Eight items where the respondent answers on a Likert scale.
The scoring is calculated based on two scales, uncertainty and certainty.
All eight items are scored twice, once for each scale.
The Likert options for the scoring of the first scale is scored 0 0 0 0 1 2 3.
The same items are then summed again with the scoring 3 2 1 0 0 0 0. All items are the summed up to give a measure of mentalization certainty and uncertainty.
|
Before treatment, after 11 weeks, following one year after the start of the treatment.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change on The Medical Outcome Social Support Survey, 12-item short form (MOS-SSS)
Time Frame: Before the treatment, during week 1 to 10 of the treatment, after 11 weeks.
|
Mediational measure of perceived social support.
Consists of six items summed up to a score between 12 and 60.
Higher scores indicate more perceived social support.
|
Before the treatment, during week 1 to 10 of the treatment, after 11 weeks.
|
Score on Interpersonal Psychotherapy Outcome Scale (IPOS)
Time Frame: Measured 11 weeks after the start of the intervention.
|
Questionnaire asking the participant to identify the focus of the treatment and the perceived change in each focus area.
Change is measured on a five-point Likert scale ranging from worsened significantly to improved greatly.
|
Measured 11 weeks after the start of the intervention.
|
Score on Credibility and Expectancy Questionnaire (CEQ)
Time Frame: Measured during week 3 of the intervention.
|
Measure of the credible the participant perceive the intervention to be as well as how beneficial they expect it to be.
Consists of six items, with four of them being answered on a nine-point Likert scale and two responses given on a ten-point Likert scale.
Scores can range between 4 and 56, with higher scores indicating greater credibility and expectancy of positive change during the intervention.
|
Measured during week 3 of the intervention.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 22, 2021
Primary Completion (Actual)
February 15, 2022
Study Completion (Actual)
February 15, 2022
Study Registration Dates
First Submitted
January 8, 2021
First Submitted That Met QC Criteria
January 21, 2021
First Posted (Actual)
January 25, 2021
Study Record Updates
Last Update Posted (Estimated)
December 11, 2023
Last Update Submitted That Met QC Criteria
December 8, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- INDIGO
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Major Depressive Disorder
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
Shalvata Mental Health CenterUnknownMAjor Depressive DisorderIsrael
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDD)India
-
Repurposed Therapeutics, Inc.Unknown
-
GlaxoSmithKlineCompletedMajor Depressive Disorder (MDD)United States
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDDIndia
-
Gangnam Severance HospitalCompletedMajor Depressive Disorder(MDD)Korea, Republic of
-
University College, LondonCompletedUnipolar Major Depressive DisorderUnited Kingdom
-
Fundació Institut de Recerca de l'Hospital de la...Fondo de Investigacion SanitariaUnknown
-
AccexibleRecruitingMajor Depressive Disorder (MDD)Spain
Clinical Trials on Interpersonal psychotherapy
-
New York State Psychiatric InstituteNot yet recruitingDepression | PTSD | Anxiety | Intimate Partner Violence
-
Hopital MontfortThe Ottawa HospitalCompletedDepression | Parkinson's DiseaseCanada
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of California, San FranciscoCompletedDepression | Posttraumatic Stress DisorderChina
-
University of IowaNational Institute of Mental Health (NIMH)Completed
-
University of Colorado, DenverAmerican Psychological Association (APA)CompletedPolycystic Ovary Syndrome | Interpersonal PsychotherapyUnited States
-
University of IowaNational Institute of Mental Health (NIMH)Terminated
-
Eunice Kennedy Shriver National Institute of Child...CompletedOverweight | Overweight AdolescentsUnited States
-
New York State Psychiatric InstituteColumbia UniversityCompletedMajor Depressive Disorder | Adjustment Disorder | Dysthymic Disorder | Depressive Disorder NOSUnited States
-
University of Wisconsin, MadisonNational Institute of Mental Health (NIMH)Completed